Medically reviewed by Faith Coleman , University of New Mexico School of Medicine on May 28th, 2026
Noguchi M, Fujimoto K, Arai G, Uemura H, Hashine K, Matsumoto H, Fukasawa S, Kohjimoto Y, Nakatsu H et al (2021) A randomized phase III trial of personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel
Related Reading: For dosing conventions, see BPC-157 Dosing Protocols
These alterations can modulate immune mechanisms, including T-cell polarization and autoantibody generation, thereby playing a role in the pathogenesis of HT (Lee et al
These peptides are claimed to support tissue regeneration, reduce inflammation, speed up recovery of muscles, tendons, ligaments, and soft tissues, and sometimes even serve as alternatives to surgery when healing is stalled
Interface-based structural prediction of novel host-pathogen interactions